Cannabis Group Weekly Alert - July 2019 #4



This week:

  • A Senate hearing on cannabis banking legislation;
  • FDA sends Curaleaf a letter alleging that certain CBD products are unapproved and misbranded drugs in violation of the FD&C;
  • While states continue to embrace industrial hemp.


The Senate Committee on Banking, Housing, and Urban Affairs conducted a hearing entitled, “Challenges for Cannabis and Banking: Outside Perspectives.” The hearing came despite public statements from Chairman Crapo (R-ID) that he is reluctant to loosen restrictions on financial institutions wishing to work with cannabis-related businesses. The witnesses included pro-cannabis industry Senators Cory Gardner (R-CO) and Jeff Merkley (D-OR); Rachel Pross, Chief Risk Officer, Maps Credit Union; Joanne Sherwood, President and CEO, Citywide Banks; Garth Van Meter, Vice President of Government Affairs, Smart Approaches to Marijuana; and John Lord, CEO and Owner, LivWell Enlightened Health. Sen. Crapo used the hearing as opportunity to criticize an Obama-era program, known as Operation Choke Point, which was intended to discourage banks from doing business with legal gun sellers and payday lenders and other companies believed to be at higher risk for fraud and money laundering—signaling that if legislation moves forward it may include other provisions less politically acceptable to Democrats.

House Judiciary Chairman Jerry Nadler (D-NY) and Senator Kamala Harris (D-CA) introduced the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) to remove cannabis from the Controlled Substances Act, decriminalize cannabis at the federal level, and require expungement or resentencing of certain past convictions. The bill also calls for a five percent tax on cannabis and cannabis-derived products, to be used to fund job training, legal aid, and state and local licensing efforts. The legislation joins a growing list of bills designed to address social justice issues relating to cannabis.

After leaving the Republican party earlier this month, Representative Justin Amash (I-MI) introduced the States Rights Cannabis Bill (H.R. 3754) to prevent the federal government from enforcing federal cannabis restrictions on individuals and entities operating legally in their states. The bill is similar to the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, but unlike the latter, does not require the federal government to study the effect of state legalization on impaired driving.

Senator Bob Menendez (D-NJ) introduced legislation to protect insurance companies that offer coverage to cannabis businesses that are operating legally in states. Known as the “CLAIM” Act, the bipartisan legislation would allow insurance companies to cover cannabis businesses and other associated businesses, such as law firms and landlords. The bill was introduced to coincide with the Senate Banking Committee’s hearing on banking issues associated with the cannabis industry in states.

A bipartisan group of House members introduced legislation to encourage medical cannabis research. The Medical Marijuana Research Act of 2019 creates a new registration process specifically for cannabis that reduces approval wait times and, once researchers have been approved, makes it easier for researchers to obtain the cannabis they need for their studies. The bill also allows for the private manufacturing and distribution of cannabis solely for research purposes. Currently, the only cannabis available for use in research legally comes from a single contract the National Institute on Drug Abuse holds with the University of Mississippi.


Alaska: Cannabis cultivators are asking the state to alter its cannabis tax system from one solely based on weight to one that combines excise and sales taxes like the systems in Nevada and Colorado. 

Arizona: Cannabis industry leaders have banded together to pursue an adult-use ballot initiative in 2020. MedMen, Curaleaf and Harvest Health & Recreation all contributed to forming the Smart and Safe Arizona campaign to support legalizing adult-use cannabis in 2020.

California: State regulators in California have turned to civil enforcement efforts to shut down unlicensed cannabis farmers. So far in 2019 the Humboldt County Planning and Building Department has sent out 148 cannabis-related “Notices to Abate” to property owners growing without a license. Possible fines are as high as $10,000 per day with a maximum fine of $900,000.

California: The California State Auditors Office examined the operations of the California Department of Consumer Affairs and the Bureau of Cannabis Control. The report acknowledged that the Bureau has effectively established a structural foundation for implementing and monitoring cannabis operations but that “the current status and location of personnel is not sustainable to provide effective and comprehensive oversight of cannabis activities throughout California.”  The Bureau only has one headquarters office, one field office, and 75 of the 219 authorized positions filled.

Massachusetts: Boston will soon have its first adult-use cannabis store. Pure Oasis was granted a provisional license to operate in the Dorchester neighborhood. The provisional license is also the first to go to members of the state’s economic empowerment program, which favors licenses for people from communities disproportionately affected by cannabis criminalization.

New Jersey: The Department of Health announced plans to expand the state’s medical cannabis program. The department is seeking to approve up to 24 additional ATCs (alternative treatment centers) across the state. The Department also stated that physicians in the state’s medical cannabis program can now authorize patients for up to 3 ounces of medical cannabis per month for up to 12 months. Finally, the state Supreme Court is set to consider whether an employee and medical cannabis patient was discriminated against in violation of the state’s Compassionate Use Medical Marijuana Act when his employer fired him after a drug test.

Utah: The state’s Department of Agriculture and Food scrapped proposed regulations to impose a residency restriction on medical cannabis cultivation licenses. More than 80 businesses have applied for one of the 10 available growing licenses.

Wisconsin:  Governor Tony Evers (D) used Twitter to express his support for medical cannabis in the state.

Hemp / CBD

The Senate Agriculture Committee has scheduled a hearing to examine hemp production since enactment of the 2018 Farm Bill. The hearing is scheduled for July 25 and will feature witnesses from the Department of Agriculture, the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA).

FDA sent a letter to Curaleaf, Inc., stating that stating that several of CuraLeaf’s CBD products contain unapproved health claims, such as “for chronic pain,” “CBD can successfully reduce anxiety symptoms,” and “CBD has also been shown to be effective in treating Parkinson’s disease,” rendering them unapproved new drugs sold in violation of the Federal Food, Drug, and Cosmetic Act. The letter also stated that the “FDA has concluded based on available evidence that CBD products are excluded from the dietary supplement definition…of the FD&C Act.”  The FDA’s action is consistent with its previous guidance, but raises questions about the breadth of the FDA’s enforcement and the immediate future of hemp-derived CBD products.

Kansas Governor Laura Kelly (D) highlighted her visit to an industrial hemp manufacturing firm in a tweet, and Kentucky Governor Matt Bevin (R) praised the opening of a $6 million CBD extraction facility operated by International Farmaceutical Extracts LLC. Both are prime examples of Midwest states embracing hemp and CBD as new economic drivers in areas characterized by slow economic recovery in the decade since the Great Recession.

Ohio has become the latest state to embrace hemp, with the state legislature passing a bill allowing farmers to plant hemp and permitting retailers to sell CBD products. The legislation removes hemp and CBD from the state’s controlled substance list and is awaiting signature from Governor Mark DeWine (R).


Canada’s Ministry of Justice has finalized a new roadside test to identify the presence of drugs. The Abbott SoToxa test can identify recent cannabis use in an individual, allowing law enforcement officials to confirm suspicions of impairment in a driver. To date, the Canadian judicial system has not ruled on whether the test passes legal muster.

British Virgin Islands Agricultural Minister Natalio Wheatley is optimistic that legislation to legalize cannabis will gain momentum in the legislature. The legislation is still in draft form and will set regulations restricting cannabis use by age and prohibiting operation of heavy machinery under the influence of THC.

India’s judicial system will consider a petition challenging the prohibition of cannabis use. The petition has been filed before Delhi’s High Court and challenges the criminalization of cannabis under the Narcotic Drugs and Psychotropic Substances Act, 1985 and Narcotic Drugs and Psychotropic Substances Rules, 1985. The High Court is set to consider the matter on July 29.

Mexico’s President Andres Manuel Lopez Obrador has directed government officials to provide an explanation for delays in regulations governing the country’s medical cannabis program. The Congress of Mexico passed legislation approving a medical cannabis program but government regulators have failed to issue regulations to govern the program. 

Switzerland’s Federal Court in Lausanne issued a ruling declaring that possession of under 10 grams of cannabis is not a punishable criminal offense. The ruling confirmed that Swiss youth and adults will not face criminal charges for possession of minor amounts of cannabis if they lack the intent to distribute.

United Kingdom’s Health Secretary Matt Hancock recently announced that medical cannabis will not need to undergo randomized controlled trials before becoming eligible for licensing. He also stated that the Medicines and Healthcare products Regulatory Agency had already started the licensing process for medical cannabis, with a decision expected this fall. A recent survey of UK adults shows growing support for cannabis legalization, with 48 percent supporting recreational use and 77 percent supporting medicinal use.


The West Hollywood Business License Commission has approved an application by Lowell Herb Co. to open the first cannabis café in the US. The café is slated to open in August and will feature a THC and CBD-infused food and drink menu in addition to a cannabis smoking area. Licenses have been issued to 15 other companies in West Hollywood to operate cannabis consumption lounges, with more openings expected in 2019 and 2020.

Curaleaf Holdings announced that it has acquired Grassroots Cannabis for $875 million. By acquiring Grassroots Cannabis, Curaleaf expands its US operations into Illinois and Michigan just as both states prepare for legalized recreational cannabis starting in 2020. The deal expands Curaleaf’s US footprint to 19 states and 68 dispensaries nationwide.

Havas has become the first advertising holding company to launch a cannabis consultancy practice. Dubbed Havas ECS, the new unit will be led by Rob Dhoble and its priority mission is to advance the understanding of cannabinoid health and wellness, with science-based education and communication programs that elevate the conversation around the human endocannabinoid system (ECS).

Jim Belushi has announced plans to launch a “Blues Brother” cannabis brand in Illinois starting in 2020. The long-time cannabis business owner will expand operations to Illinois when recreational cannabis becomes legal in 2020 as part of a coordinated effort to launch a national cannabis brand.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dentons | Attorney Advertising

Written by:


Dentons on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit
  • New Relic - For more information on New Relic cookies, please visit
  • Google Analytics - For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.